Synthace Ltd

11 articles about Synthace Ltd

• 

  Sofinnova Nets $1B+ from Apollo to Accelerate Biotech Growth

  5/16/2022

  Sofinnova Partners announced on Monday that it entered into a long-term strategic and financial partnership with Apollo to expand its presence in the life sciences.
• 

  BioSpace Movers & Shakers, May 21

  5/21/2021

  Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.

• Veteran Technology Executive Joins Synthace to Accelerate its Mission to Revolutionize the Life Science Research Market

  5/19/2021

  Synthace Ltd, the cloud-based software platform for automating biological R&D, announced the appointment of Guy Levy-Yurista as Chief Executive Officer and Board Member to guide Synthace through its next stage of growth.

• Synthace More Than Doubles Its Annual Recurring Revenue; Expands Customer Footprint With the Top Pharma Companies In 2020

  3/25/2021

  Strong financial performance and the achievement of other key milestones demonstrate the growing strength of Synthace’s offering within the biopharma and biotech industries.

• Synthace Appoints Dr. Nick Jurascheck as VP of Engineering

  3/9/2021

  Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, announced the appointment of Nick Jurascheck as VP of Engineering.

• Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development Through Automation

  11/5/2020

  Two European leaders in biopharma and integrative software are working together to advance drug discovery

• Synthace Announces the Launch of New Product Helping Scientists Execute and Scale Key Assays

  10/7/2020

  Leading Computer-Aided Biology company develops an innovative new approach to automating the ELISA

• Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation  

  6/11/2020

  Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, and the Tecan Group announce a partnership to deepen the integration between Synthace’s Antha software and Tecan’s Te-Chrom™ automated chromatography system to unlock the full potential of miniaturized protein purification.

• Gilson and Synthace Announce Collaboration Aiming to Make Biological Research More Efficient and Reproducible at Analytica 2018

  4/10/2018

  Synthace’s Antha Software Makes Gilson’s PIPETMAX More Flexible and Easier to Use

• Synthace Ltd Raises £7.3 Million To Accelerate Biotechnology To Enable Faster Breakthroughs

  9/19/2017

• Synthace Ltd Partners With Microsoft To Bring Antha To Azure

  4/6/2016